In vivo selection of CD4+ T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat

Human Gene Therapy

Volumn 23, Issue 9, 2012, Pages 917-931

  Braun, Stephen E ^a,d   Taube, Ran ^b,e   Zhu, Quan ^b   Wong, Fay Eng ^a   Murakami, Akikazu ^b   Kamau, Erick ^b   Dwyer, Markryan ^b   Qiu, Gang ^a   Daigle, Janet ^b   Carville, Angela ^a   Johnson, R Paul ^a,c   Marasco, Wayne A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1 TAT ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; RETROVIRUS VECTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL ENGINEERING; CELL LOSS; CELL SELECTION; CELL STIMULATION; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; DNA MODIFICATION; EX VIVO STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LYMPH NODE CELL; MACACA; MARKER GENE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN TARGETING; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL GENE THERAPY; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; GAMMARETROVIRUS; GENE EXPRESSION; HIV ANTIBODIES; HIV-1; HUMANS; LYMPHOCYTE TRANSFUSION; MACACA MULATTA; SINGLE-CHAIN ANTIBODIES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; TRANSDUCTION, GENETIC;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84866308671     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.184     Document Type: Article

References (67)

1. Amado, R.G., Mitsuyasu, R.T., Rosenblatt, J.D., et al. (2004). Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum. Gene Ther. 15, 251-262. (Pubitemid 38365914)
2. Apolloni, A., Hooker, C.W., Mak, J., and Harrich, D. (2003). Human immunodeficiency virus type 1 protease regulation of tat activity is essential for efficient reverse transcription and replication. J. Virol. 77, 9912-9921. (Pubitemid 37122072)
3. Bahner, I., Sumiyoshi, T., Kagoda, M., et al. (2007). Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Mol. Ther. 15, 76-85. (Pubitemid 46043652)
4. Bai, J., Sui, J., Zhu, R.Y., et al. (2003). Inhibition of Tat-mediated transactivation and HIV-1 replication by human antihCyclinT1 intrabodies. J. Biol. Chem. 278, 1433-1442. (Pubitemid 36801368)
5. Balazs, A.B., Chen, J., Hong, C.M., et al. (2012). Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481, 81-84.
6. Baltimore, D. (1988). Gene therapy. Intracellular immunization. Nature 335, 395-396.
7. Berger, C., Huang, M.L., Gough, M., et al. (2001). Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model. J. Virol. 75, 799-808. (Pubitemid 32037283)
8. Brass, A.L., Dykxhoorn, D.M., Benita, Y., et al. (2008). Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926. (Pubitemid 351263756)
9. Braun, S.E., and Johnson, R.P. (2006). Setting the stage for benchto-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques. Front. Biosci. 11, 838-851. (Pubitemid 43258185)
10. Bunnell, B.A., Metzger, M., Byrne, E., et al. (1997). Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89, 1987-1995. (Pubitemid 27132114)
11. Clerici, M., Villa, M.L., Trabattoni, D., and Shearer, G.M. (2003). The breakdown of the cytokine network subsequent to human immunodeficiency virus infection. J. Gen. Virol. 64, 1649-1661.
12. DiGiusto, D.L., Krishnan, A., Li, L., et al. (2010). RNA-based gene therapy for HIV with lentiviral vector-modified CD34 (+) cells in patients undergoing transplantation for AIDS-related lymphoma. Sci. Transl. Med. 2, 36-43.
13. Donahue, R.E., Kirby, M.R., Metzger, M.E., et al. (1996). Peripheral blood CD34 + cells differ from bone marrow CD34 + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colonystimulating factor and/or stem cell factor. Blood 87, 1644-1653.
14. Donahue, R.E., Bunnell, B.A., Zink, M.C., et al. (1998). Reduction in Siv replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nat. Med. 4, 181-186. (Pubitemid 28137372)
15. Galati, D., Bocchino, M., Paiardini, M., et al. (2002). Cell cycle dysregulation during HIV infection: perspectives of a target based therapy. Curr Drug Targets Immune Endocr. Metab. Disord. 2, 53-61.
16. Gennari, F., Mehta, M., Wang, Y., et al. (2004). Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-jB transactivation. J. Mol. Biol. 335, 193-207. (Pubitemid 37494972)
17. Gerard, C.J., Arboleda, M.J., Solar, G., et al. (1996). A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses. Hum. Gene Ther. 7, 343-354.
18. Hanazono, Y., Brown, K.E., Handa, A., et al. (1999). In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectors. Blood 94, 2263-2270. (Pubitemid 29467674)
19. Hanenberg, H., Hashino, K., Konishi, H., et al. (1997). Optimization of fibronectin-assisted retroviral gene transfer into human CD34 + hematopoietic cells. Hum. Gene Ther. 8, 2193-2206. (Pubitemid 28043557)
20. Hannon, G.J., and Rossi, J.J. (2004). Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378. (Pubitemid 39265678)
21. Harrich, D., McMillan, N., Munoz, L., et al. (2006). Will diverse Tat interactions lead to novel aniretroviral drug targets? Curr. Drug Targets 7, 1595-1606. (Pubitemid 44873721)
22. Humeau, L.M., Binder, G.K., Lu, X., et al. (2004). Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV + infected patients grouped according to CD4 count and viral load. Mol. Ther. 9, 902-913. (Pubitemid 38878136)
23. Jacque, J.M., Triques, K., and Stevenson, M. (2002). Modulation of HIV-1 replication by RNA interference. Nature 418, 435-438. (Pubitemid 34826845)
24. Johnson, P.R., Schnepp, B.C., Zhang, J., et al. (2009). Vectormediated gene transfer engenders long-lived neutralizing activity and protection against Siv infection in monkeys. Nat. Med. 15, 901-906.
25. Kang, E.M., De Witte, M., Malech, H., et al. (2002). Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood 99, 698-701. (Pubitemid 34533111)
26. Kawai, T., Wong, J., Maclean, J., et al. (1994). Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant. Proc. 26, 1845-1846. (Pubitemid 24260745)
27. Kimpel, J., Braun, S.E., Qiu, G., et al. (2010). Survival of the fittest: positive selection of CD4 + T cells expressing a membranebound fusion inhibitor following HIV-1 infection. PLoS One 5, e12357.
28. Kinsella, T.M., and Nolan, G.P. (1996). Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405-1413. (Pubitemid 26293560)
29. Klebba, C., Ottmann, O.G., Scherr, M., et al. (2000). Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4 + T cells in vitro. Gene Ther. 7, 408-416. (Pubitemid 30156553)
30. Kö nig, R., Zhou, Y., Elleder, D., et al. (2008). Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication. Cell 135, 49-60.
31. Kozal MJ. (2009). Drug-resistant human immunodefiency virus. Clin. Microbiol. Infect. 15(Suppl 1), 69-73.
32. Kumar, P., Ban, H.S., Kim, S.S., et al. (2008). T cell-specific sirna delivery suppresses HIV-1 infection in humanized mice. Cell 134, 577-586.
33. Levine, B.L., Humeau, L.M., Boyer, J., et al. (2006). Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 103, 17372-17377. (Pubitemid 44788976)
34. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. (Pubitemid 34164012)
35. Lo, A., Zhu, Q., and Marasco, W.A. (2008). Intracellular antibodies (intrabodies) and their therapeutic potential. Handb. Exp. Pharmacol. 181, 343-373.
36. Macpherson, J.L., Boyd, M.P., Arndt, A.J., et al. (2005). Longterm survival and concomitant gene expression of ribozymetransduced CD4+ T-lymphocytes in HIV-infected patients. J. Gene Med. 7, 552-564. (Pubitemid 40744521)
37. Marasco, W.A., and Sui, J. (2007). The growth and potential of human antiviral monoclonal antibody therapeutics. Nat. Biotechnol. 25, 1421-1434. (Pubitemid 350233138)
38. Marasco, W.A., Lavecchio, J., and Winkler, A. (1999). Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. J. Immunol. Methods 231, 223-238. (Pubitemid 30394736)
39. Matheux, F., Lauret, E., Rousseau, V., et al. (2000). Simian immunodeficiency virus resistance of macaques infused with interferon beta-engineered lymphocytes. J. Gen. Virol. 81, 2741-2750.
40. Mhashilkar, A.M., Bagley, J., Chen, S.Y., et al. (1995). Inhibition of HIV-1 Tat-mediated Ltr transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J. 14, 1542-1551.
41. Mhashilkar, A.M., Lavecchio, J., Eberhardt, B., et al. (1999). Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4 + mononuclear cells expressing murine and humanized antihuman immunodeficiency virus type 1 Tat single-chain variable fragment intrabody. Hum. Gene Ther. 10, 1453-1467. (Pubitemid 29318983)
42. Michienzi, A., Castanotto, D., Lee, N., et al. (2003). RNAmediated inhibition of HIV in a gene therapy setting. Ann. N. Y. Acad. Sci. 1002, 63-71. (Pubitemid 38253330)
43. Mitsuyasu, R.T., Merigan, T., Carr, A., et al. (2009). Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 + cells. Nat. Med. 15, 285-292.
44. Morgan, R.A., Walker, R., Carter, C.S., et al. (2005). Preferential survival of CD4 + T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals. Hum. Gene Ther. 16, 1065-1074. (Pubitemid 41324566)
45. Nathans, R., Cao, H., Sharova, N., et al. (2008). Small-molecule inhibition of HIV-1 Vif. Nat. Biotechnol. 26, 1187-1192.
46. Ngok, F.K., Mitsuyasu, R.T., Macpherson, J.L., et al. (2004). Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS. Methods Mol Biol 252, 581-598.
47. Nishimura, Y., Brown, C.R., Mattapallil, J.J., et al. (2005). Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc. Natl. Acad. Sci. U. S. A. 102, 8000-8005. (Pubitemid 40781052)
48. Novina, C.D., Murray, M.F., Dykxhoorn, D.M., et al. (2002). siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8, 681-686. (Pubitemid 34778720)
49. Palmer, E., Liu, H., Khan, F., et al. (2006). Enhanced cell-free protein expression by fusion with immunoglobulin Cj domain. Protein Sci. 15, 2842-2846. (Pubitemid 44833765)
50. Peruzzi, F. (2006). The multiple functions of HIV-1 Tat: proliferation versus apoptosis. Front. Biosci. 11, 708-717. (Pubitemid 43258174)
51. Pitcher, C.J., Hagen, S.I., Walker, J.M., et al. (2002). Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168, 29-43. (Pubitemid 34014099)
52. Podsakoff, G., Engel, B., Carbonaro, D.A., et al. (2005). Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34 (+) cells. Mol. Ther. 12, 77-86. (Pubitemid 40862359)
53. Pollok, K.E., Hanenberg, H., Noblitt, T.W., et al. (1998). Highefficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J. Virol. 72, 4882-4892. (Pubitemid 28215666)
54. Poznansky, M.C., Foxall, R., Mhashilkar, A., et al. (1998). Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat. Hum. Gene Ther. 9, 487-496. (Pubitemid 28149602)
55. Poznansky, M.C., La Vecchio, J., Silva-Arietta, S., et al. (1999). Inhibition of human immunodeficiency virus replication and growth advantage of CD4 + T cells and monocytes derived from CD34 + cells transduced with an intracellular antibody directed against human immunodeficiency virus type 1 Tat. Hum. Gene Ther. 10, 2505-2514. (Pubitemid 29489724)
56. Romani, B., Engelbrecht, S., and Glashoff, R.H. (2010). Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J. Gen. Virol. 91, 1-12.
57. Rossi, J.J., June, C.H., and Kohn, D.B. (2007). Genetic therapies against HIV. Nat. Biotechnol. 25, 1444-1454. (Pubitemid 350233141)
58. Sarver, N., Cantin, E.M., Chang, P.S., et al. (1990). Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225.
59. Sodora, D.L., Lee, F., Dailey, P.J., and Marx, P.A. (1998). A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Res. Hum. Retroviruses 14, 171-181. (Pubitemid 28063528)
60. Swan, C.H., Bü hler, B., Steinberger, P., et al. (2006). T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. Gene Ther. 13, 1480-1492. (Pubitemid 44480530)
61. The Institute Of Laboratory Animal Research COLS, National Research Council. (1996). Guide for the Care and Use of Laboratory Animals. (National Academy Press, Washington, DC).
62. Trobridge, G.D., Wu, R.A., Beard, B.C., et al. (2009). Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection. PLoS One 4, e7693.
63. van Lunzen, J., Glaunsinger, T., Stahmer, I., et al. (2007). Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. Mol. Ther. 15, 1024-1033. (Pubitemid 46621662)
64. Veazey, R.S., Tham, I.C., Mansfield, K.G., et al. (2000). Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4+ T cells are rapidly eliminated in early Siv infection in vivo. J. Virol. 74, 57-64. (Pubitemid 30002883)
65. Von Laer, D., Hasselmann, S., and Hasselmann, K. (2006). Impact of gene-modified T cells on HIV infection dynamics. J. Theor. Biol. 238, 60-77. (Pubitemid 41737797)
66. Woffendin, C., Ranga, U., Yang, Z., et al. (1996). Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. U. S. A. 93, 2889-2894. (Pubitemid 26116244)
67. Zhang, D., Murakami, A., Johnson, R.P., et al. (2003). Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies. J. Acquir. Immune Defic. Syndr. 32, 245-254. (Pubitemid 36331695)